Brief: Pharmiva Q2 Oper Loss Narrows To SEK 6 Mln
16/08/2023 07:35
Aug 16 (Reuters) - Pharmiva AB (publ) PHARM.ST :
* SECOND QUARTER FINANCIAL REPORT
* IN Q2 NET TURNOVER SEK 897,00 VERSUS SEK 669,00 YEAR AGO
* Q2 OPERATING LOSS SEK 6 MILLION VERSUS SEK 7.4 MILLION YEAR AGO
Source text for Eikon: ID:nMFN5PKfz4
Further company coverage: PHARM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pharmiva AB (publ)
See all newsBrief: Merger Between Peptonic, Pharmiva Creates Leading Global Femtech Company
Brief: Pharmiva Q2 Oper Loss Narrows To SEK 6 Mln
Brief: Pharmiva, Peptonic Announce Merger Plan
Brief: Pharmiva AB Prelim Jan-May Operating Loss Narrows To SEK 8.9 Mln
Brief: Pharmiva Q1 Loss Before And After Tax Narrows To SEK 5.3 Mln